Lawmakers included a set of proposed amendments that hospitals say soften its severity, although they remain opposed.
Click here to view original post
Related Articles
News
Yes, We Should Be Concerned About the Health Effects of Vaping
June 9, 2025
UCBN
News, Syndication
Comments Off on Yes, We Should Be Concerned About the Health Effects of Vaping
Here’s some news worth celebrating: Fewer Americans than ever are smoking cigarettes. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
Boulder biotech unloads muscular dystrophy drug for up to $2.65 billion
July 13, 2026
UCBN
News, Syndication
Comments Off on Boulder biotech unloads muscular dystrophy drug for up to $2.65 billion
The company received $1.55 billion in cash, but is eligible for an additional $1.1 billion in additional payments if it hits regulatory and commercial milestones. Click here to view original post Click Here to Publish/Feature […]
News
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 10, 2026
UCBN
News, Syndication
Comments Off on Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today […]
